JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IBDQ
3501
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $2.56M | ﹤0.01% |
102,987
+664
| +0.6% | +$16.4K |
2019 Q4
17 quarters
|
|
3502
Invesco China Technology ETF
CQQQ
$2.5B
| $2.55M | ﹤0.01% |
79,679
-2,252
| -3% | -$71.4K |
2020 Q3
14 quarters
|
|
3503
PUT
NIO
NIO
$8.77B
| $2.55M | ﹤0.01% |
+566,300
| New | +$3.41M |
2024 Q1
0 quarters
|
|
|
INBX
3504
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.54M | ﹤0.01% |
72,764
+21,238
| +41% | +$775K |
2020 Q4
13 quarters
|
|
3505
Columbia Research Enhanced Core ETF
RECS
$6.14B
| $2.54M | ﹤0.01% |
82,085
+13,737
| +20% | +$402K |
2023 Q4
1 quarter
|
|
3506
CALL
Ambarella
AMBA
$2.91B
| $2.54M | ﹤0.01% |
+50,000
| New | +$2.73M |
2024 Q1
0 quarters
|
|
|
3507
PUT
Ambarella
AMBA
$2.91B
| $2.54M | ﹤0.01% |
+50,000
| New | +$2.73M |
2024 Q1
0 quarters
|
|
|
QHY
3508
WisdomTree U.S. High Yield Corporate Bond Fund
QHY
$244M
| $2.54M | ﹤0.01% |
56,018
+2,892
| +5% | +$131K |
2023 Q3
2 quarters
|
|
3509
CALL
West Pharmaceutical
WST
$26.3B
| $2.53M | ﹤0.01% |
6,400
+5,000
| +357% | +$1.85M |
2023 Q3
2 quarters
|
|
|
AVNS
3510
DELISTED
Avanos Medical
AVNS
| $2.53M | ﹤0.01% |
127,118
-76,110
| -37% | -$1.47M |
2014 Q4
37 quarters
|
|
3511
Healthcare Services Group
HCSG
$1.45B
| $2.53M | ﹤0.01% |
202,662
-101,867
| -33% | -$1.13M |
2013 Q2
43 quarters
|
|
3512
CALL
Cytokinetics
CYTK
$8.56B
| $2.52M | ﹤0.01% |
36,000
+23,500
| +188% | +$1.82M |
2023 Q4
1 quarter
|
|
3513
Ameresco
AMRC
$1.14B
| $2.52M | ﹤0.01% |
104,411
+3,228
| +3% | +$72.3K |
2017 Q4
25 quarters
|
|
3514
PUT
Alpha Metallurgical Resources
AMR
$2.14B
| $2.52M | ﹤0.01% |
+7,600
| New | +$2.79M |
2024 Q1
0 quarters
|
|
3515
iShares MSCI Hong Kong ETF
EWH
$1.14B
| $2.51M | ﹤0.01% |
161,509
+11,323
| +8% | +$183K |
2013 Q2
43 quarters
|
|
3516
Origin Bancorp
OBK
$1.61B
| $2.51M | ﹤0.01% |
80,281
+10,850
| +16% | +$337K |
2018 Q2
23 quarters
|
|
|
SRTA
3517
Strata Critical Medical Inc
SRTA
$418M
| $2.5M | ﹤0.01% |
878,675
+164,990
| +23% | +$509K |
2022 Q1
8 quarters
|
|
3518
CALL
Johnson Controls International
JCI
$93.9B
| $2.5M | ﹤0.01% |
38,300
+14,700
| +62% | +$856K |
2023 Q4
1 quarter
|
|
3519
ALPS Equal Sector Weight ETF
EQL
$745M
| $2.5M | ﹤0.01% |
63,606
+618
| +1% | +$23.1K |
2023 Q4
1 quarter
|
|
3520
FT Vest US Equity Deep Buffer ETF January
DJAN
$454M
| $2.5M | ﹤0.01% |
69,354
+69,180
| +39,759% | +$2.44M |
2023 Q3
2 quarters
|
|
3521
Energy Recovery
ERII
$340M
| $2.5M | ﹤0.01% |
158,232
+80,306
| +103% | +$1.28M |
2013 Q2
43 quarters
|
|
3522
iShares MSCI Italy ETF
EWI
$1.14B
| $2.49M | ﹤0.01% |
66,041
+21,976
| +50% | +$769K |
2023 Q2
3 quarters
|
|
3523
iShares MSCI Spain ETF
EWP
$2.33B
| $2.49M | ﹤0.01% |
77,427
+55,413
| +252% | +$1.67M |
2020 Q4
13 quarters
|
|
3524
A10 Networks
ATEN
$2.07B
| $2.49M | ﹤0.01% |
181,834
+6,856
| +4% | +$92.2K |
2014 Q2
39 quarters
|
|
3525
Global X MLP & Energy Infrastructure ETF
MLPX
$3.47B
| $2.49M | ﹤0.01% |
50,791
-255,986
| -83% | -$11.7M |
2021 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.